Abstract
Rationale: Impulsive behavior is categorically differentiated between impulsive action, the inability to withhold from acting out a response, and impulsive choice, the greater preference for an immediate and smaller reward over a delayed but more advantageous reward. While the effects of N-methyl-d-aspartic acid (NMDA) receptor antagonists on impulsive action have been extensively characterized, there are very few and conflicting reports on the effects of this class of drugs on impulsive choice. Objectives: Using a modified adjusting delay task, we investigated the effects of uncompetitive and competitive blockade of NMDA receptors on impulsive choice. Methods: Male Wistar rats were trained in a modified adjusting delay task, which involved repeated choice between a low reinforcing solution delivered immediately and a highly reinforcing solution delivered after a variable delay. Rats were then administered either the NMDA receptor uncompetitive antagonists ketamine or memantine, or the competitive antagonists D-AP-5 or CGS 19755. Results: Ketamine treatment dose-dependently increased impulsive choice, and this effect was selective for low-impulsive but not high-impulsive rats. Similarly, memantine treatment dose-dependently increased impulsive choice with a preferential effect for low-impulsive rats. While D-AP-5 treatment did not affect impulsive choice, CGS 19755 increased impulsivity, however, at the same doses at which it caused a marked response inhibition. Conclusions: NMDA receptor uncompetitive, but not competitive, antagonists significantly increased impulsive choice, preferentially in low-impulsive rats. These findings demonstrate that the effects of NMDA receptor blockade on impulsive choice are not generalizable and depend on the specific mechanism of action of the antagonist used.
Original language | English (US) |
---|---|
Pages (from-to) | 127-138 |
Number of pages | 12 |
Journal | Psychopharmacology |
Volume | 226 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2013 |
Funding
Acknowledgments of funding This publication was made possible by grant numbers DA023680, DA030425, MH091945, MH093650A1 and AA016731 from the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), by the Peter Paul Career Development Professorship (P.C.), and by Boston University's Undergraduate Research Opportunities Program (UROP) (A.R.N., J.K.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The authors declare no conflict of interest. The authors declare no conflict of interest.
Keywords
- CGS 19755
- D-AP-5 or AP-5 or D-AP5 or AP5
- Decision making
- Delay discounting
- Glutamate
- Impulsive choice
- Impulsivity
- Ketamine
- Memantine
- NMDA receptor antagonist
ASJC Scopus subject areas
- Pharmacology